Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw
Open Access
- 12 April 2018
- journal article
- research article
- Published by SAGE Publications in JDR Clinical & Translational Research
- Vol. 3 (3) , 222-225
Abstract
Knowledge Transfer Statement: This article discusses the proceedings of the conference organized by the Task Force on Design and Analysis in Oral Health Research on the understanding of the translational evidence on the etiology and pathogenesis of medication-related osteonecrosis of the jaw as well as the clinical protocols on patient management.Keywords
Funding Information
- Amgen (2014586784)
- Division of Cancer Prevention, National Cancer Institute (R01CA206105)
- National Institute of Dental and Craniofacial Research (R01DE019465)
- National Institute of Dental and Craniofacial Research (R01DE025992)
- Oral Maxillofacial Surgery Foundation
This publication has 6 references indexed in Scilit:
- Pathophysiology of Osteonecrosis of the JawsOral and Maxillofacial Surgery Clinics of North America, 2015
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International ConsensusJournal of Bone and Mineral Research, 2014
- Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: A novel ONJ mouse modelBone, 2014
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014
- Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jawInternational Journal of Oral Science, 2014
- Periapical Disease and Bisphosphonates Induce Osteonecrosis of the Jaws in MiceJournal of Bone and Mineral Research, 2013